NCT00457587

Preclinical Study Towards an Immunotherapy in Adrenocortical Carcinoma

Präklinische Studie Zur Etablierung Einer Immuntherapie für Das Nebennierenrindenkarzinom - Preclinical Study Towards an Immunotherapy in Adrenocortical Carcinoma

• Status: Active Not Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 150 (actual)
• Sponsor: University of Wuerzburg · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

Adrenocortical carcinoma (ACC) is a rare and heterogeneous malignancy with poor prognosis. Surgical resection of the tumor is the treatment of choice. However, even after complete resection more than 80 % of patients will experience recurrence of disease. Therefore, new treatment options are urgently needed. This pre-clinical study try to lay the foundations for a successful immunotherapy in patients with ACC.

Conditions

• Adrenocortical Carcinoma
• Cushing's Syndrome

Timeline

• Start date: 2005-09-01
• Primary completion: 2027-12-01
• Completion: 2028-12-01
• First posted: 2007-04-06
• Last updated: 2025-08-26

Locations

1 site across 1 country: Germany